Making Access to a Population of Bodies in the Name of Autonomy

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Making Access to a Population of Bodies in the Name of Autonomy. / Asmussen, Ida Helene; Ó Cathaoir, Katharina Eva.

In: European Journal of Health Law, Vol. 25, No. 5, 2018, p. 555-572.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Asmussen, IH & Ó Cathaoir, KE 2018, 'Making Access to a Population of Bodies in the Name of Autonomy', European Journal of Health Law, vol. 25, no. 5, pp. 555-572. <https://brill.com/view/journals/ejhl/25/5/ejhl.25.issue-5.xml>

APA

Asmussen, I. H., & Ó Cathaoir, K. E. (2018). Making Access to a Population of Bodies in the Name of Autonomy. European Journal of Health Law, 25(5), 555-572. https://brill.com/view/journals/ejhl/25/5/ejhl.25.issue-5.xml

Vancouver

Asmussen IH, Ó Cathaoir KE. Making Access to a Population of Bodies in the Name of Autonomy. European Journal of Health Law. 2018;25(5):555-572.

Author

Asmussen, Ida Helene ; Ó Cathaoir, Katharina Eva. / Making Access to a Population of Bodies in the Name of Autonomy. In: European Journal of Health Law. 2018 ; Vol. 25, No. 5. pp. 555-572.

Bibtex

@article{e72481c1d087483c8b07873f8cd8909a,
title = "Making Access to a Population of Bodies in the Name of Autonomy",
abstract = "Developments within biotechnology are of a pace and complexity that challenge the predictability at the foundation of legislation, i.e. the possibility for politicians to foresee pitfalls and hazards, and design legislation accordingly. The lack of predictability is not only a challenge for the legislature, but also for the citizen, who is to consent to the new biotech services offered by the health authorities. How can one give informed consent to a measure, the consequences of which is hard to predict? Does the uncertainty and lack of predictability mean that paternalism slipped back in as a 'self-selected' responsiveness to the rhetoric of the health regime? Recently, Denmark has taken another step in the direction of voiding autonomy of actual value by rendering genetic analysis contingent on agreeing that the resulting data may be stored in the recently established National Genome Centre, and reused for research unless the patient opts out.",
author = "Asmussen, {Ida Helene} and {{\'O} Cathaoir}, {Katharina Eva}",
year = "2018",
language = "English",
volume = "25",
pages = "555--572",
journal = "European Journal of Health Law",
issn = "0929-0273",
publisher = "Brill - Nijhoff",
number = "5",

}

RIS

TY - JOUR

T1 - Making Access to a Population of Bodies in the Name of Autonomy

AU - Asmussen, Ida Helene

AU - Ó Cathaoir, Katharina Eva

PY - 2018

Y1 - 2018

N2 - Developments within biotechnology are of a pace and complexity that challenge the predictability at the foundation of legislation, i.e. the possibility for politicians to foresee pitfalls and hazards, and design legislation accordingly. The lack of predictability is not only a challenge for the legislature, but also for the citizen, who is to consent to the new biotech services offered by the health authorities. How can one give informed consent to a measure, the consequences of which is hard to predict? Does the uncertainty and lack of predictability mean that paternalism slipped back in as a 'self-selected' responsiveness to the rhetoric of the health regime? Recently, Denmark has taken another step in the direction of voiding autonomy of actual value by rendering genetic analysis contingent on agreeing that the resulting data may be stored in the recently established National Genome Centre, and reused for research unless the patient opts out.

AB - Developments within biotechnology are of a pace and complexity that challenge the predictability at the foundation of legislation, i.e. the possibility for politicians to foresee pitfalls and hazards, and design legislation accordingly. The lack of predictability is not only a challenge for the legislature, but also for the citizen, who is to consent to the new biotech services offered by the health authorities. How can one give informed consent to a measure, the consequences of which is hard to predict? Does the uncertainty and lack of predictability mean that paternalism slipped back in as a 'self-selected' responsiveness to the rhetoric of the health regime? Recently, Denmark has taken another step in the direction of voiding autonomy of actual value by rendering genetic analysis contingent on agreeing that the resulting data may be stored in the recently established National Genome Centre, and reused for research unless the patient opts out.

M3 - Journal article

VL - 25

SP - 555

EP - 572

JO - European Journal of Health Law

JF - European Journal of Health Law

SN - 0929-0273

IS - 5

ER -

ID: 203566174